PET and PET/CT for unknown primary tumors.

Area of Science:

• Oncology
• Radiology
• Nuclear Medicine

Background:

• Carcinoma of unknown primary (CUP) represents metastatic cancer without a detectable primary tumor after standard work-up.
• CUP is a frequent malignancy associated with a poor prognosis.
• Identifying the primary tumor is critical for targeted treatment and improved patient outcomes.

Purpose of the Study:

• To evaluate the utility of combined positron emission tomography/computed tomography (PET/CT) in detecting primary tumors in patients with CUP.
• To discuss the role of FDG-PET/CT in the diagnostic management of CUP.
• To explore challenges and future directions in CUP diagnosis.

Main Methods:

• Review of the syndrome of Carcinoma of unknown primary (CUP).
• Outline of the rationale, use, and utility of (18)F-fluoro-2-deoxyglucose (FDG)-PET/CT in CUP management.
• Discussion of diagnostic challenges and future research directions.

Main Results:

• Standard diagnostic work-up for CUP can be time-consuming, costly, and burdensome.
• The diagnostic yield of conventional tests for CUP is often limited.
• Combined FDG-PET/CT may significantly aid in detecting the primary tumor in CUP patients.

Conclusions:

• Combined FDG-PET/CT is a valuable tool for the detection of primary tumors in patients with Carcinoma of unknown primary (CUP).
• This imaging modality offers potential benefits in guiding definitive treatment and improving patient prognosis.
• Further research is needed to address current challenges and optimize diagnostic strategies for CUP.